ACTX yields 2000000.00% · JNJ yields 2.14%● Live data
📍 ACTX pulled ahead of the other in Year 1
Combined, ACTX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACTX + JNJ for your $10,000?
Advanced Container Technologies, Inc. engages in designing, branding, and selling plastic medical grade containers. It markets and sells GrowPods, a specially modified insulated shipping containers in which plants, herbs, and spices grown hydroponically in a controlled environment; and the Medtainer that is used to store pharmaceuticals, herbs, teas, and other solids or liquids, and can grind solids and shred herbs, as well as related products. The company also provides private labeling and branding services for purchasers of Medtainers and other related products. In addition, it offers lighters, humidity pack inserts, plastic lighter holders, jars, and mylar bags; and printing and shipping services. Further, the company provides growing media consists of premium soils and soil alternatives, such as perlite, gravel, rock wool, and coconut coir or clay pebbles used in hydroponic cultivation under the Prolific Soilless Growth Medium and Prolific Fertilizer names; and LED lighting, electronically controlled irrigation systems, humidifiers, and growing panels as replacement parts and upgrades. It markets its products and services directly to businesses through its phone room to the retail public through internet sales, and directly to wholesalers and other businesses that resell its products to other businesses and end users. The company is headquartered in Corona, California.
Full ACTX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.